Vaxcyte, Inc.

Healthcare · Biotechnology · United States

Last price 62.03 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 9.76B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused b...